1.
A considerable increase in the plasminogen activator content in the internal jugular venous blood as compared with that in the arterial blood was found in fifty patients.
2. Inhalation of 5 % carbon dioxide in air was associated with increased plasminogen activator content in blood from the internal jugular vein in all the eight patients treated in this way.
3. It is suggested that the human brain makes a contribution of plasminogen activator to the circulation of the body and that the amount contributed is determined by the rate of the blood flow.
The plasminogen activator content in the circulating blood has hitherto been thought to derive largely from the endothelium of the veins (Messer, Celander & Guest, 1962; Chakrabarti, Birks & Fearnley, 1963; Warren, 1964; Fearnley, 1965) though this has been difficult to prove. Pandolfi and his colleagues (1967) , for instance, believe that the plasminogen activator is liberated from the vasa vasorum of the veins, and it has recently been suggested that the blood during its passage through the kidneys (Menon & Dewar, 1967; Menon, 1968a, b; Menon, Dewar & Newell, 1968b) and muscles (Menon et al., 1968a; Menon, 1969) also receives this factor from the organs mentioned.
The present investigation was carried out in order to examine the part the brain might play in the contribution of activators to the blood. With this object we investigated the plasminogen activator content in blood obtained from the internal jugular veins in man and compared it with that in blood from other sites in the venous system (especially the subclavian vein and the right atrium) and also with the plasminogen activator content in an artery.
Inhalation of 5% carbon dioxide in air for 10 min has been shown to increase cerebral blood flow (Kety & Schmidt, 1948a) . This procedure was carried out on eight patients and the acti- vator content of blood from the internal jugular vein, subclavian vein, right atrium and an artery before and after inhalation, was compared.
M A T E R I A L A N D M E T H O D S
During cardiac catheterization undertaken for the investigation of heart disease, blood samples were collected before heparin was given from forty-two patients who were sedated with 100 mg quinalbarbitone sodium. All the patients were free from signs of congestive cardiac failure and central cyanosis. Most suffered from rheumatic valvular disease and a few from congenital malformations.
Venous blood was obtained by right heart catheterization and arterial blood by direct puncture of the femoral or brachial artery.
Right heart catheterization was performed using a teflon catheter which after insertion into the femoral vein was advanced centrally under fluoroscopic visualization to the inferior vena cava and the right atrium. The catheter was then manipulated into a subclavian vein and an internal jugular vein.
Before catheterization was commenced local anaesthetic (1 % lignocaine) was administered at the puncture site of the femoral vein.
Blood was withdrawn from an internal jugular vein in fifty patients, from a subclavian vein in forty-three, from the right atrium in forty-nine and from the brachial or femoral artery in fifty. The variation in the number of sites from which blood was taken from different patients were due to technical difficulties. Confirmation that the blood was obtained from the respective venous sites was established by the anatomical appearance of the blood vessels and heart chamber under the X-ray screen.
From this study the activator content in the internal carotid artery was assumed to be the same as that in a brachial or femoral artery. This assumption would appear to be justifiable since it has been shown in an earlier study (Menon, Weightman & Dewar, 1969 ) that the activator content in the left atrium was similar to that in blood from a femoral or brachial artery
(P> 0.8).
After obtaining the first samples eight patients were asked to inhale 5% carbon dioxide in air for 10 min. Subsequently a further blood sample was withdrawn from the veins mentioned above and an artery.
The euglobulin lysis time (ELT) was estimated by the method described by von Kaulla (1963) slightly modified by Menon (1967) : freshly obtained plasma was diluted with distilled water in the proportions 1 : 15 and the euglobulin precipitated with carbon dioxide. The precipitate was centrifuged, suspended in buffer and clotted with thrombin. The lysis time was obtained by observation of the clot in a transparent bath at a constant temperature of 37". The end point is reached when the clot is completely disintegrated. All the procedures, before incubation of the clot, were carried out at 0".
The advantages of this method, apart from its reproducibility, are that large groups of patients can be compared and that some conclusions can be drawn about the nature of the fibrinolytic system.
All estimations in this study were made in duplicate. In a previous study duplicate samples of blood in rapid succession were taken for control purposes from thirty healthy medical students and analysed for ELT. No statistically significant difference was found ( P > 0.2).
ELT has been expressed in units by multiplying the reciprocal of the lysis time in minutes by 10 OOO. In fibrinolytic assays it has been shown that activity is a direct function of the reciprocal of the lysis time and accordingly a logarithmic plot of lysis against units of activity shows a linear relationship (Sherry & Alkjaersig, 1957) . Sherry et al. (1959) suggested that euglobulin lysis times could usefully be expressed in terms of arbitrary units of activity derived from such a plot. Moreover, we believe that by expressing the ELT in such units rather than in minutes, the interpretation of the results is facilitated since the higher the value the greater the activator content and vice versa .
R E S U L T S
For the correct interpretation of the results we feel that some elaboration with regard to the methods used is necessary.
The small amount of local anaesthetic used at the site of the needle puncture is unlikely to produce any change in the fibrinolytic activity. We had previously investigated this change in ten normal subjects whose ELT was estimated by comparing samples of blood taken from the sites of puncture in the anterior cubital vein before and after administration of local anaesthetic. No significant difference in ELT was found between the two samples (E-0.9).
It must be stressed that no heparin was given during cardiac catheterization until all the blood specimens for our investigation had been withdrawn.
Though all samples from the internal jugular and subclavian veins were obtained 5-15 min after withdrawal of the right atrial blood it is unlikely that the fibrinolytic activity would change during so short a period. We have investigated the ELT in the femoral artery at time intervals varying between 15 and 30 min. No significant difference in lysis times was observed (P> 0-09). Similarly, the results of our investigation of blood from subclavian veins collected during cardiac catheterization at time intervals of 15-30 min failed to show any noteworthy difference in the lysis times (P> 0.7) (Menon et al., 1968a) .
A comparison between the activator content in the blood samples from an internal jugular vein and a subclavian vein of the same side and the right atrium showed no significant difference. On the other hand, when blood from an internal jugular vein was compared with that from a peripheral artery the activator content in the former was invariably greater (Tables 1  and 2 ) giving a statistical significance of P<O.OOl.
The finding that the activator content in blood from an internal jugular vein is higher than in that from an artery confirms the belief that the brain contributes activators to the blood.
Evidence that the internal jugular vein contained mixed cerebral venous blood which is not contaminated by blood from extra-cerebral sources has been submitted by Kety & Schmidt (1948b) . The fact that the activator content in the internal jugular venous blood was approximately the same as in the subclavian venous blood suggests that the contribution from the brain is similar to that from resting muscles but considerably less than the very large contribution from the kidneys (Menon, Dewar & Newell, 1968b) . Tables 3 and 4 show a marked increase of the plasminogen activator content in the blood from the internal jugular vein after inhalation of 5% carbon dioxide in air (P<O.Ol). Similarly, an increase was found from the right atrium (P<0.02) but this was probably due to it being mixed with blood from the internal jugular vein. On the other hand, there was no significant 10 OOO Lysis time (min) Units = difference between the plasminogen activator level in the blood obtained from the arterial sites and the subclavian veins before and after inhalation.
The study demonstrates that after inhalation of 5% carbon dioxide in air the activator content in the internal jugular vein is increased presumably due to a greater amount of activators being released from the cerebral parenchyma into the internal jugular vein. This is further confirmation that the brain is an independent contributor of plasminogen activators to the blood and is consistent with the view that the amount of plasminogen activator provided by the brain is probably influenced by the rate of the cerebral blood flow, although other possible effects of COz inhalation cannot be excluded.
In the present series information was not obtained as to the amount by which the cerebral blood flow increased after the inhalation of 5% carbon dioxide in air. It seems likely, however, that it was considerably less than the increase which would have followed the inhalation by normal people since a previous study (Dewar & Davidson, 1958) of twenty-five cases of mitral stenosis without congestive heart failure showed that the cerebral blood flow is 39 ml min-' 100 g of brain-'. After inhalation of 5% carbon dioxide in air this blood flow was increased in the patients by an average of 31% as against 75% in normal subjects after similar inhalation (Kety &Schmidt, 1948b) .
D I S C U S S I O N
The implication of the findings mentioned in relation to the general concept of how the level of plasminogen activators in the circulating blood is maintained is of great interest. It has been shown (Menon et al., 1968b ) that in a similar group of patients the kidneys add an average increment of 40.6 units of plasminogen activators to the blood circulating through them. If it is accepted that in patients with heart disease but no congestive cardiac failure the renal blood flow constitutes 14.8% of the cardiac output (Wade & Bishop, 1962) this would indicate that an average increase of 6% of the plasminogen activator content in the systemic blood is contributed by the kidney. If it is further accepted that the cerebral blood flow in patients with heart disease but no congestive cardiac failure amounts to 10% of the cardiac output (Wade & Bishop, 1962) it follows that the brain contributes 2.7% of the activator content in the blood.
It has also been demonstrated (Menon, Muscat-Baron & Dewar, 1968c) in a similar group of subjects that the splanchnic circulation decreases the level of plasminogen activators in the blood by 6.8 units, and again if it is accepted that in these patients the splanchnic flow constitutes 20% of the cardiac output (Wade & Bishop, 1962) then the liver and other splanchnic viscera can be assumed to be responsible for reducing the content of plasminogen activators by an average of 1.36%. The lungs, on the other hand, reduce the plasminogen activator content in the circulation by 16.7% and consequently the lungs and liver together reduce the plasminogen activator content by an average of 18.06% (16*7+ 1.36). Since this removal is only offset by an average contribution of 6% from the kidneys and 2.7% from the brain it is obvious that a substantial amount must come from some other sources. Work is in progress which seems to indicate that the heart, suprarenals, ovaries, testes, stomach, skin and uterus are among these sources. 
